APA (7th ed.) Citation

DK, D., MM, D., SMH, N., DW, O., TJ, H., MS, B., . . . JS, Z. (2025). A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases. Cancer, 131(1), e35636. https://doi.org/10.1002/cncr.35636

Chicago Style (17th ed.) Citation

DK, DePalo, et al. "A Comparison of Isolated Limb Infusion/perfusion, Immune Checkpoint Inhibitors, and Intralesional Therapy as First-line Treatment for Patients with Melanoma In-transit Metastases." Cancer 131, no. 1 (2025): e35636. https://doi.org/10.1002/cncr.35636.

MLA (9th ed.) Citation

DK, DePalo, et al. "A Comparison of Isolated Limb Infusion/perfusion, Immune Checkpoint Inhibitors, and Intralesional Therapy as First-line Treatment for Patients with Melanoma In-transit Metastases." Cancer, vol. 131, no. 1, 2025, p. e35636, https://doi.org/10.1002/cncr.35636.